Literature DB >> 10386475

Reply to Labrie et al. Results of the mortality analysis of the Quebec Randomized/controlled trial (RCT)

F E Alexander, R J Prescott.   

Abstract

Mesh：

Year:  1999        PMID： 10386475     DOI： 10.1002/(sici)1097-0045(19990701)40:2<135::aid-pros11>3.0.co;2-y

Source DB:  PubMed          Journal:  Prostate        ISSN： 0270-4137            Impact factor:   4.104


× No keyword cloud information.
  4 in total

1.  Does PSA screening reduce prostate cancer mortality?

Authors:  André N Vis
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

2.  Cost-effectiveness analysis of prostate cancer screening.

Authors:  C Hamashima; K Yoshida
Journal:  Environ Health Prev Med       Date:  2000-10       Impact factor: 3.674

3.  PSA screening and prostate cancer mortality.

Authors:  Linda Perron; Lynne Moore; Isabelle Bairati; Paul-Marie Bernard; François Meyer
Journal:  CMAJ       Date:  2002-03-05       Impact factor: 8.262

Review 4.  Current status of PSA screening. Early detection of prostate cancer.

Authors:  Tom Pickles
Journal:  Can Fam Physician       Date:  2004-01       Impact factor: 3.275
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.